Roche cobas 8000 modular analyzer series — Class II medical device recall Z-0754-2021
Ongoing recall by Roche Diagnostics Operations, Inc., reported 2021-01-06, distributed nationwide. Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated so
| Recall number | Z-0754-2021 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Roche Diagnostics Operations, Inc., Indianapolis, IN, United States |
| Recall initiated | 2020-12-08 |
| Classified | 2020-12-30 |
| Reported by FDA | 2021-01-06 |
| Distributed | Nationwide (US) |
| Quantity | 1,050 units |
| Serial numbers | 1017-01, 1017-04, 1019-09, 1020-01, 1022-05, 1029-09, 1030-08, 1030-09, 1030-10, 1034-09, 1036-07, 1138-03, 1138-04, 1140-09, 1140-10, 1142-01, 1142-02, 1142-04, 1142-05, 1142-06, 1142-08, 1142-09, 1142-10, 1143-01, 1143-06 and 475 more |
| Model numbers | 08763662001 |
Product
Roche cobas 8000 modular analyzer series (i.e., cobas 8000 ISE module; cobas c 502, 701, and 702 modules; and cobas e 602 and 801 modules). Chemistry Analyzer (photometric discrete), for clinical use Part Number: 08763662001
Reason for recall
Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated solutions, may cause incorrect results in several affected parameters. In the case of poor sample quality, discrepant results may remain undetected due to the absence of associated data flags.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0754-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.